A more detailed understanding about the role of CAMKK2 in activation of the tyrosine phosphoproteome and, in particular, PTK2/JUN/STAT3 signaling in gastric cancer is needed, in addition to functional studies in preclinical models, which is beyond the scope of this article. The gene discussed is PTK2; the disease is gastric cancer.